90 related articles for article (PubMed ID: 1771541)
1. [A new oral prostaglandin E1 derivative (OP 1206) compared with intravenous PGE1: assessment of the effect on macro- and microcirculation].
Scheffler P; de la Hamette D; Pindur G; Gross J; Darbringhaus S
Vasa Suppl; 1991; 32():386-91. PubMed ID: 1771541
[No Abstract] [Full Text] [Related]
2. [Double-blind study of the effect of various intra-arterial/intravenous prostaglandin E1 doses on hemodynamics and prostaglandin E1 metabolites].
Rudofsky G; Peskar BA
Vasa Suppl; 1991; 33():345. PubMed ID: 1788751
[No Abstract] [Full Text] [Related]
3. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
Scheffler P; de la Hamette D; Leipnitz G
Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
[TBL] [Abstract][Full Text] [Related]
4. Effects of intra-arterial administration of prostaglandin E1 on rat cremaster muscle microcirculation.
Natsui H; Yanagi K; Nakayama Y; Ohshima N
In Vivo; 2001; 15(2):133-8. PubMed ID: 11317517
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of intravenously applied prostaglandin E1.
Scheffler P; de la Hamette D; Leipnitz G
Vasa Suppl; 1989; 28():19-25. PubMed ID: 2609240
[TBL] [Abstract][Full Text] [Related]
6. Effects of OP-1206 (prostaglandin E1) on nerve-conduction velocity in the dog cauda equina subjected to acute experimental compression.
Konno S; Kayama S; Olmarker K; Kikuchi S
J Spinal Disord; 1996 Apr; 9(2):103-6. PubMed ID: 8793775
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
Scheffler P; Birkel L; Grub KR; de la Hamette D
Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
[No Abstract] [Full Text] [Related]
8. A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome.
Vincent JL; Brase R; Santman F; Suter PM; McLuckie A; Dhainaut JF; Park Y; Karmel J
Intensive Care Med; 2001 Oct; 27(10):1578-83. PubMed ID: 11685297
[TBL] [Abstract][Full Text] [Related]
9. The effect of prostaglandin E1 on nailfold capillary blood pressure and red blood cell velocity in humans.
Hahn M; Jünger M; Shore AC
Clin Hemorheol Microcirc; 2004; 31(3):227-34. PubMed ID: 15322328
[TBL] [Abstract][Full Text] [Related]
10. Effects of pentoxifylline and alprostadil on ocular hemodynamics in healthy humans.
Dorner GT; Zawinka C; Resch H; Wolzt M; Schmetterer L; Garhofer G
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):815-9. PubMed ID: 17251482
[TBL] [Abstract][Full Text] [Related]
11. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
Creutzig A; Caspary L; Alexander K
Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
[No Abstract] [Full Text] [Related]
12. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
[TBL] [Abstract][Full Text] [Related]
13. Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation.
Saeki S; Yamamura K; Matsushita M; Nishikimi N; Sakurai T; Nimura Y
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):525-9. PubMed ID: 9799055
[TBL] [Abstract][Full Text] [Related]
14. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
[TBL] [Abstract][Full Text] [Related]
15. Capillary blood cell velocity in periulcerous regions of the lower leg measured by laser Doppler anemometry.
Stücker M; Huntermann C; Bechara FG; Hoffmann K; Altmeyer P
Skin Res Technol; 2004 Aug; 10(3):174-7. PubMed ID: 15225267
[TBL] [Abstract][Full Text] [Related]
16. [Prostaglandin E1 in intermittent claudication].
Scheffler P; de la Hamette D; Rogatti W
Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
[No Abstract] [Full Text] [Related]
17. Experimental study of the effect of intraportal prostaglandin E1 on hepatic blood flow during reperfusion after ischaemia and hepatectomy.
Hossain MA; Hamamoto I; Wakabayashi H; Goda F; Kobayashi S; Maeba T; Maeta H
Br J Surg; 1999 Jun; 86(6):776-83. PubMed ID: 10383578
[TBL] [Abstract][Full Text] [Related]
18. [Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension].
Pan S; Xiao M; Liu Y
Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):276-9. PubMed ID: 9387702
[TBL] [Abstract][Full Text] [Related]
19. Effects of lipo-prostaglandin E1 on wound bed microcirculation.
Hasegawa H; Ichioka S
J Wound Care; 2015 Jul; 24(7):293-4, 296, 298-9. PubMed ID: 26198551
[TBL] [Abstract][Full Text] [Related]
20. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
